Candido Kenneth D, Sukhani Radha, Doty Robert, Nader Antoun, Kendall Mark C, Yaghmour Edward, Kataria Tripti C, McCarthy Robert
Department of Anesthesiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.
Anesth Analg. 2005 May;100(5):1489-1495. doi: 10.1213/01.ANE.0000148696.11814.9F.
We determined the incidence, distribution, and resolution of neurologic sequelae and the association with anesthetic, surgical, and patient factors after single-injection interscalene block (ISB) using levobupivacaine 0.625% with epinephrine 1:200,000 in subjects undergoing shoulder or upper arm surgery, or both, in 693 consecutive adult patients. After a standardized ISB, assessments were made at 24 and 48 h and at 2 and 4 wk for anesthesia, hypesthesia, paresthesias, pain/dysesthesias, and motor weakness. Symptomatic patients were monitored until resolution. Subjects reporting pain or discomfort >3 of 10 and those with motor or extending sensory symptoms received diagnostic assessment. Six-hundred-sixty subjects completed 4 wk of follow-up. Fifty-eight neurologic sequelae were reported by 56 subjects. Symptoms were sensory except for two cases of motor weakness (lesions identified distant from the ISB site). Thirty-one sequelae with likely ISB association were reported by 29 subjects, including 14 at the ISB site, 9 at the distal phalanx of thumb/index finger, 7 involving the posterior auricular nerve, and 1 clinical brachial plexopathy. Sequelae not likely associated with the ISB were reported by 27 subjects with symptoms reported in the median (n = 9) and ulnar (n = 4) nerves, surgical neuropraxias (n = 12), and motor weakness (n = 2). Symptoms resolved spontaneously (median 4 wk; range, 2-16 wk) except in the two patients with motor weaknesses and the patient with clinical brachial plexopathy, who received therapeutic interventions. Variables identified as independent predictors of neurologic sequelae likely related to ISB were paresthesia at needle insertion and ISB site pain or bruising at 24 h. In contrast, surgery preformed in the sitting position, as well as ISB site bruising, was identified as a predictor of neurologic sequelae not likely related to ISB. In conclusion, neurologic sequelae after single-injection ISB using epinephrine mainly involve transient minor sensory symptoms.
我们确定了693例连续成年患者在接受肩部或上臂手术或两者皆有的手术时,使用0.625%左旋布比卡因与1:200,000肾上腺素进行单次肌间沟阻滞(ISB)后神经后遗症的发生率、分布、缓解情况以及与麻醉、手术和患者因素的关联。在标准化ISB后,分别于24小时和48小时以及2周和4周时进行麻醉、感觉减退、感觉异常、疼痛/感觉障碍和运动无力方面的评估。对有症状的患者进行监测直至症状缓解。报告疼痛或不适程度>10分制中的3分的受试者以及有运动或扩展性感觉症状的受试者接受诊断评估。660名受试者完成了4周的随访。56名受试者报告了58例神经后遗症。除两例运动无力(病变位于距ISB部位较远)外,症状均为感觉性。29名受试者报告了31例可能与ISB相关的后遗症,包括14例位于ISB部位,9例位于拇指/示指远端指骨,7例累及耳后神经,以及1例临床臂丛神经病变。27名受试者报告了不太可能与ISB相关的后遗症,症状出现在正中神经(n = 9)和尺神经(n = 4)、手术性神经失用(n = 12)以及运动无力(n = 2)。除了两名运动无力患者和一名临床臂丛神经病变患者接受了治疗干预外,症状均自发缓解(中位时间4周;范围,2 - 16周)。被确定为可能与ISB相关的神经后遗症的独立预测因素的变量为针刺时感觉异常以及24小时时ISB部位疼痛或瘀斑。相比之下,坐位进行的手术以及ISB部位瘀斑被确定为不太可能与ISB相关的神经后遗症的预测因素。总之,使用肾上腺素进行单次注射ISB后的神经后遗症主要涉及短暂的轻微感觉症状。